Online citations, reference lists, and bibliographies.
← Back to Search

Breast Cancer Special Types: Why Bother?

J. Reis-Filho, S. Lakhani
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Breast cancer is a heterogeneous disease, encompassing multiple entities associated with distinct biological features and clinical behaviours. Microarray‐based expression profiling analysis has been used to unravel the molecular underpinning of several characteristics of breast cancer, including its proclivity to disseminate to distant sites and the molecular basis of histological grade. Furthermore, a breast cancer molecular classification based on transcriptional analysis has been proposed. However, microarray studies have primarily analysed invasive ductal carcinomas of no special type. Histological special types of breast cancer, which account for up to 25% of all invasive breast cancers, have not been systematically studied. Despite the limited interest, in recent years it has become apparent that the histopathological characteristics of these cancers may be underpinned by distinct arrays of genetic changes, providing direct evidence for genotypic–phenotypic correlations between morphological patterns and molecular changes in breast cancer (eg t(12;15) in secretory carcinoma of the breast). Here we review the molecular characteristics of special types of breast cancer, with special emphasis on their microarray‐based expression profiles and their impact on our understanding of breast cancer. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
This paper references
10.1158/1078-0432.CCR-05-1633
High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer
D. Stange (2006)
10.1158/0008-5472.CAN-05-4414
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.
A. V. Ivshina (2006)
10.1016/S1040-8428(99)00034-7
Pathological prognostic factors in breast cancer.
C. Elston (1999)
10.1201/b14447-28
Invasive breast carcinoma
S. Alsam (2005)
10.1002/path.2358
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
P. Simpson (2008)
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
J. (2002)
Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6 ‘split apart
JS Reis-Filho (2008)
JS Reis-Filho and SR Lakhani invasion in breast cancer and has important clinical consequences
 Copyright (2007)
Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.
Y. J. Lu (1998)
10.1038/sj.bjc.6602794
No common denominator for breast cancer lymph node metastasis
B. Weigelt (2005)
10.1097/01.pap.0000138142.26882.fe
Carcinomas with Micropapillary Morphology: Clinical Significance and Current Concepts
H. Nassar (2004)
10.1038/35101087
Microarray and histopathological analysis of tumours: the future and the past?
Sunil R. Lakhani (2001)
10.1002/path.1845
Typical medullary breast carcinomas have a basal/myoepithelial phenotype
J. Jacquemier (2005)
10.1038/sj.onc.1210014
BRCA1 dysfunction in sporadic basal-like breast cancer
N. Turner (2007)
10.1073/PNAS.96.16.9212
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
C. Perou (1999)
Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.
R. Roylance (1999)
10.1038/sj.onc.1209876
Basal-like breast cancer and the BRCA1 phenotype
N. Turner (2006)
Gene expression and benefit of chemotherapy in women with nodenegative, estrogen receptor-positive breast cancer
S Paik (2008)
10.1097/00000478-200306000-00016
Special Types of Invasive Breast Cancer, With Clinical Implications
D. Page (2003)
10.1016/S1077-9108(08)79164-3
Refinement of breast cancer classification by molecular characterization of histological special types
G. Azabdaftari (2009)
10.1046/j.1365-2559.2002.01336.x
Neuroendocrine differentiation and prognosis in breast adenocarcinoma
A. Miremadi (2002)
10.1038/89022
Microarrays—the 21st century divining rod?
Y. He (2001)
10.1091/MBC.E03-11-0786
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
H. Zhao (2004)
10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N
Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up
R. Ridolfi (1977)
10.1038/nrc2193
Modelling breast cancer: one size does not fit all
T. Vargo-Gogola (2007)
10.1158/0008-5472.CAN-04-1992
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes
L. Loo (2004)
10.1038/nrc1670
Breast cancer metastasis: markers and models
B. Weigelt (2005)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1038/sj.onc.1208561
Identification of molecular apocrine breast tumours by microarray analysis
P. Farmer (2005)
10.1016/0046-8177(92)90321-S
Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.
V. Eusebi (1992)
10.1111/j.1365-2559.2008.03046.x
Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes
J. Reis-Filho (2008)
The molecular outlook
C Caldas (2002)
10.1111/j.1365-2559.1991.tb00229.x
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
C. Elston (1991)
10.1093/ANNONC/12.SUPPL_2.S115
Clinical significance of neuroendocrine carcinoma of the breast.
A. Sapino (2001)
Array comparative genomic hybridization analysis of genomic alterations in breast cancer
LW Loo (2004)
10.1053/S0046-8177(03)00411-8
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
N. Makretsov (2003)
10.1158/0008-5472.CAN-07-5644
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
10.1016/S1535-6108(02)00180-0
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
C. Tognon (2002)
10.1016/S0140-6736(05)17947-1
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Y. Wang (2005)
10.1002/path.1806
Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity
J. Reis-Filho (2005)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
H Zhao (2004)
10.1038/415530a
Gene expression profiling predicts clinical outcome of breast cancer
L. J. Veer (2002)
10.1634/theoncologist.2007-0216
Current status of prognostic profiling in breast cancer.
L. Pusztai (2008)
10.1002/path.1691
Molecular evolution of breast cancer
P. Simpson (2005)
10.1038/ncponc0587
Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practice
Ambreen Abdullah-Sayani (2006)
10.1097/PAS.0b013e318161d1a5
Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family
T. Abdel-Fatah (2008)
10.1111/j.1365-2559.1992.tb01032.x
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up
I. Ellis (1992)
10.1002/path.2124
A mouse model of basal‐like breast carcinoma with metaplastic elements
A. Mccarthy (2007)
10.1002/path.2368
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
C. Marchiò (2008)
10.1093/ANNONC/MDL006
Biphasic metaplastic sarcomatoid carcinoma of the breast.
B. Hennessy (2006)
10.1038/sj.onc.1210593
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial–mesenchymal transition
H. C. Lien (2007)
10.1158/1078-0432.CCR-06-2765
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
C. Desmedt (2007)
10.1002/path.875
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution
H. Buerger (2001)
10.1093/JNCI/DJJ329
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
M. Buyse (2006)
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.
J. Korkola (2003)
10.1136/jcp.2005.028324
The impact of expression profiling on prognostic and predictive testing in breast cancer
J. Reis-Filho (2006)
10.1016/J.PRP.2005.05.013
The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.
J. Reis-Filho (2005)
10.1038/labinvest.3700551
Why microscopy will remain a cornerstone of surgical pathology
J. Rosai (2007)
10.1093/JNCI/DJJ052
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
C. Sotiriou (2006)
10.1200/JCO.2005.04.7985
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
S. Paik (2006)
10.1038/nrc2173
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
C. Sotiriou (2007)
10.1093/JNCI/90.15.1138
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
S. Lakhani (1998)
10.1046/j.1365-2559.1997.5720795.x
Prognostic comparison of three classifications for medullary carcinomas of the breast
M. Lidang Jensen (1997)
10.1038/onc.2008.158
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles
F. Bertucci (2008)
10.1097/PAS.0b013e31806841f6
Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences
R. Mohammed (2007)



This paper is referenced by
10.1002/path.2763
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type
M. Lacroix-Triki (2010)
10.1007/978-1-4419-1030-1_5
Prognostication and Prediction in Anatomic Pathology: Carcinoma of the Breast as an Illustrative Model
M. Wick (2011)
10.1136/jcp.2011.089862
Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification
C. Alvarenga (2011)
Family History among Iraqi Patients Diagnosed with Breast Cancer
N. Alwan (2017)
10.3233/BD-2010-0319
Epidemiology of triple negative breast cancers.
G. Gierach (2010)
10.36472/msd.v6i9.288
Analysis of breast true-cut biopsies by applying immunohistochemical study of myoepithelial markers
M. G. Balci (2019)
10.1038/modpathol.2009.112
Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type
B. Weigelt (2009)
10.1002/path.2648
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
B. Weigelt (2010)
10.1007/s13277-016-5349-7
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications
Vida Pourteimoor (2016)
Tumor and Stem Cell Biology CCR 5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Marco Velasco-Vel (2012)
Short communication Next-generation sequencing
J. Reis-Filho ()
Discovery of novel prognostic tools to stratify high risk stage II colorectal cancer patients utilising digital pathology
Peter David Caie (2015)
10.1136/jclinpath-2012-200885
Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes
C. Alvarenga (2012)
10.17140/SROJ-1-104
Epidemiologic Analysis of the Surgical Specimens of Breast Carcinosarcomas Examined at a Reference Laboratory in a Nigerian Community
Wilson I. B. Onuigbo (2015)
Adjuvant tamoxifen in breast cancer : clinical and preclinical studies on the prediction value of estrogen receptor
Mahmoud R. Khoshnoud (2010)
10.1111/jog.13840
Comprehensive analysis of coexpressed long noncoding RNAs and genes in breast cancer
Y. Dong (2019)
Triple negative and basal-like breast cancer : one or many diseases ? Implications for surgical pathologists
J. Reis-Filho (2009)
Antiproliferative and antiangiogenic effects of metformin on multidrug-resistant MCF-7 cells
L. Yang (2018)
Expression distributio of the breast cancer stem cells markers CD44/CD24 within special histological types
Pedro Nuno Pinho Caetano (2012)
10.1016/j.amsu.2019.07.011
Predictive factors affecting axillary lymph node involvement in patients with breast cancer in Duhok: Cross-sectional study
A. Mohammed (2019)
10.1186/bcr2431
Next-generation sequencing
J. Reis-Filho (2009)
10.11606/T.5.2014.TDE-24102014-102346
Fatores morfológicos, moleculares e do microambiente relacionados ao risco de invasão estromal em carcinomas ductais in situ da mama
Fernando Nalesso Aguiar (2014)
10.1158/1541-7786.MCR-18-0284
Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs
M. Sang (2018)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA: CIÊNCIAS MÉDICAS EXPRESSÃO DE MARCADORES DE CÉLULAS-TRONCO TUMORAIS EM CARCINOMAS MAMÁRIOS BASAIS E PENTANEGATIVOS - ESTUDO EM UMA SÉRIE DE TUMORES TRIPLONEGATIVOS
Diego de Mendonça Uchoa (2012)
10.1016/B978-1-4160-5766-6.00014-5
Chapter 10 – Immunohistology of Endocrine Tumors
R. DeLellis (2011)
10.1158/0008-5472.CAN-11-3917
CCR5 antagonist blocks metastasis of basal breast cancer cells.
M. Velasco-Velázquez (2012)
10.1016/B978-0-12-801238-3.65263-7
Breast Cancer—Pathology and Genetics
A. E. M. Reed (2018)
10.5772/54979
Serial Changes in Expression of Proteins in Response to Neoadjuvant Chemotherapy in Breast Cancer
D. Chan (2013)
10.1038/srep00264
Transcriptomic landscape of breast cancers through mRNA sequencing
J. Eswaran (2012)
Cell Cycle Regulatory Roles of Estrogen Receptor alpha (ERα) in Breast Cancer Cells
Sonia JavanMoghaddam (2011)
10.2217/fon.10.97
Potential role of PI3K inhibitors in the treatment of breast cancer.
S. Carvalho (2010)
10.1007/S12558-012-0206-5
Profil moléculaire du carcinome micropapillaire invasif du sein
Faten Hammedi (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar